Influenza vaccination modifies disease severity among community-dwelling adults hospitalized with influenza

Clinical Infectious Diseases

Volumn 65, Issue 8, 2017, Pages 1289-1297

  Arriola, Carmen ^a   Garg, Shikha ^a   Anderson, Evan J ^b,c   Ryan, Patrician A ^d   George, Andrea ^e   Zansky, Shelley M ^f   Bennett, Nancy ^g   Reingold, Arthur ^h   Bargsten, Marisa ⁱ   Miller, Lisa ^j   Yousey Hindes, Kimberly ^k   Tatham, Lilith ^l   Bohm, Susan R ^m   Lynfield, Ruth ⁿ   Thomas, Ann ^o   Lindegren, Mary Lou ^p   Schaffner, William ^p   Fry, Alicia M ^a   Chaves, Sandra S ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

^d MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^e Salt Lake City Fire Department (SLCFD)   (United States)

^f New York Emerging Infections Program   (United States)

^g UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^h California Emerging Infections Program   (United States)

ⁱ New Mexico Emerging Infections Program   (Argentina)

^j Colorado Department of Public Health and Environment ^*  (United States)

^k YALE UNIVERSITY   (United States)

^l OHIO DEPARTMENT OF HEALTH   (United States)

^m MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

ⁿ MINNESOTA DEPARTMENT OF HEALTH   (United States)

^o Oregon Public Health Division   (Portugal)

^p VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Adults; Disease severity; Influenza vaccination

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CLINICAL OUTCOME; COMMUNITY LIVING; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL DISCHARGE; HOSPITAL MORTALITY; HOSPITAL PATIENT; HUMAN; INFLUENZA VACCINATION; INTENSIVE CARE UNIT; LABORATORY TEST; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ONSET AGE; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PROPENSITY SCORE; RISK FACTOR; RISK REDUCTION; SEASONAL INFLUENZA; ADOLESCENT; IMMUNOLOGY; INFLUENZA; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; UNITED STATES; VACCINATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PROPENSITY SCORE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; UNITED STATES; VACCINATION; YOUNG ADULT;

EID: 85030176637     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix468     Document Type: Article

References (39)

1. Kostova D, Reed C, Finelli L, et al. Influenza illness and hospitalizations averted by influenza vaccination in the United States, 2005-2011. PLoS One 2013; 8:e66312.
2. Centers for Disease Control and Prevention. FluVaxView. 2016 Available at: http://www.cdc.gov/flu/fluvaxview/. Accessed 26 May 2016.
3. Health, R. Seasonal Flu Vaccination: Why Don't More Americans Get It? Research Highlights, Rand Health, 2011.
4. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44.
5. Arriola CS, Anderson EJ, Baumbach J, et al. Does influenza vaccination modify influenza severity? Data on older adults hospitalized with influenza during the 2012-2013 season in the United States. J Infect Dis 2015; 212:1200-8.
6. Casado I, Domínguez A, Toledo D, et al; Project Pi12/2079 Working Group. Effect of influenza vaccination on the prognosis of hospitalized influenza patients. Expert Rev Vaccines 2016; 15:425-32.
7. Patriarca PA, Weber JA, Parker RA, et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA 1985; 253:1136-9.
8. Ruben FL, Johnston F, Streiff EJ. Influenza in a partially immunized aged population. Effectiveness of killed Hong Kong vaccine against infection with the England strain. JAMA 1974; 230:863-6.
9. Centers for Disease Control and Prevention. Seasonal influenza Vaccine Effectiveness, 2005-2015. 2015 Available at: http://www.cdc.gov/flu/professionals/vaccination/effectiveness-studies.htm. Accessed 17 November 2015.
10. McLean HQ, Thompson MG, Sundaram ME, et al. Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type. J Infect Dis 2015; 211:1529-40.
11. Fry AM, Kim IK, Reed C, et al. Modeling the effect of different vaccine effectiveness estimates on the number of vaccine-prevented influenza-associated hospitalizations in older adults. Clin Infect Dis 2014; 59:406-9.
12. Valenciano M, Ciancio B, Moren A; Influenza Vaccine Effectiveness Working Group. First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States. Euro Surveill 2008; 13.
13. Arriola CS, Brammer L, Epperson S, et al; Centers for Disease Control and Prevention (CDC). Update: influenza activity - United States, September 29, 2013-February 8, 2014. MMWR Morb Mortal Wkly Rep 2014; 63:148-54.
14. Gaglani M, Pruszynski J, Murthy K, et al. Influenza vaccine effectiveness against 2009 pandemic influenza A(H1N1) virus differed by vaccine type during 2013-2014 in the United States. J Infect Dis 2016; 213:1546-56.
15. Chaves SS, Lynfield R, Lindegren ML, Bresee J, Finelli L. The US Influenza Hospitalization Surveillance Network. Emerg Infect Dis 2015; 21:1543-50.
16. Arriola CS, Chaves SS. Reply to Chughtai et al. J Infect Dis 2015; 212:1684-5.
17. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006; 24:1159-69.
18. Herrera GA, Iwane MK, Cortese M, et al. Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004. Vaccine 2007; 25:154-60.
19. Reber AJ, Chirkova T, Kim JH, et al. Immunosenescence and challenges of vaccination against influenza in the aging population. Aging Dis 2012; 3:68-90.
20. Williamson EJ, Forbes A, Introduction to propensity scores. Respirology 2014; 19:625-35.
21. Rosenbaum PR, Rubin DB. The bias due to incomplete matching. Biometrics 1985; 41:103-16.
22. Rubin DB, Thomas N. Matching using estimated propensity scores: relating theory to practice. Biometrics 1996; 52:249-64.
23. Davison AC, Hinkley DV, eds. Bootstrap Methods and Their Application. New York: Cambridge University Press, 1997.
24. Reed C, Chaves SS, Daily Kirley P, et al. Estimating influenza disease burden from population-based surveillance data in the United States. PLoS One 2015; 10:e0118369.
25. Flannery B, Zimmerman RK, Gubareva LV, et al. Enhanced genetic characterization of influenza A(H3N2) viruses and vaccine effectiveness by genetic group, 2014-2015. J Infect Dis 2016; 214:1010-9.
26. Chaves SS, Pérez A, Miller L, et al. Impact of prompt influenza antiviral treatment on extended care needs after influenza hospitalization among community-dwelling older adults. Clin Infect Dis 2015; 61:1807-14.
27. Fry AM, Goswami D, Nahar K, et al. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial. Lancet Infect Dis 2014; 14:109-18.
28. Lee N, Chan PK, Hui DS, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009; 200:492-500.
29. Jhung MA, Swerdlow D, Olsen SJ, et al. Epidemiology of 2009 pandemic influenza A (H1N1) in the United States. Clin Infect Dis 2011; 52 Suppl 1:S13-26.
30. Grijalva CG, Zhu Y, Williams DJ, et al. Association between hospitalization with community-acquired laboratory-confirmed influenza pneumonia and prior receipt of influenza vaccination. JAMA 2015; 314:1488-97.
31. Joshi M, Chandra D, Mittadodla P, Bartter T. The impact of vaccination on influenza-related respiratory failure and mortality in hospitalized elderly patients over the 2013-2014 season. Open Respir Med J 2015; 9:9-14.
32. Catania J, Que LG, Govert JA, Hollingsworth J W, Wolfe CR. High intensive care unit admission rate for 2013-2014 influenza is associated with a low rate of vaccination. Am J Respir Crit Care Med 2014; 189:485-7.
33. Deiss RG, Arnold JC, Chen WJ, et al. Vaccine-associated reduction in symptom severity among patients with influenza A/H3N2 disease. Vaccine 2015; 33:7160-7.
34. Castilla J, Godoy P, Domínguez A, et al; CIBERESP Cases and Controls in Influenza Working Group Spain. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Clin Infect Dis 2013; 57:167-75.
35. Jain VK, Rivera L, Zaman K, et al. Vaccine for prevention of mild and moderate-to-severe influenza in children. N Engl J Med 2013; 369:2481-91.
36. Remschmidt C, Wichmann O, Harder T. Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review. BMC Infect Dis 2015; 15:429.
37. Hak E, Hoes AW, Nordin J, Nichol KL. Benefits of influenza vaccine in US elderly-appreciating issues of confounding bias and precision. Int J Epidemiol 2006; 35:800-2; author reply 799-800.
38. Wong K, Campitelli MA, Stukel TA, Kwong JC. Estimating influenza vaccine effectiveness in community-dwelling elderly patients using the instrumental variable analysis method. Arch Intern Med 2012; 172:484-91.
39. O'Hagan JJ, Wong KK, Campbell A P, et al. Estimating the United States demand for influenza antivirals and the effect on severe influenza disease during a potential pandemic. Clin Infect Dis 2015; 60 Suppl 1:S30-41.